{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:33:53Z","timestamp":1792593233356,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020723","name":"Chhatrapati Shahu Maharaj Research Training and Human Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejpb.2023.05.020","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T22:19:54Z","timestamp":1685657994000},"page":"15-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Design, development, and in-vitro\/in-vivo evaluation of docetaxel-loaded PEGylated solid lipid nanoparticles in prostate cancer therapy"],"prefix":"10.1016","volume":"189","author":[{"given":"Swati","family":"Korake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bothiraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atmaram","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2023.05.020_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119088","article-title":"Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance","volume":"578","author":"Kaushik","year":"2020","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ejpb.2023.05.020_b0010","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","article-title":"Global patterns of cancer incidence and mortality rates and trends","volume":"19","author":"Jemal","year":"2010","journal-title":"Cancer Epidemiol. Prevent. Biomarkers"},{"key":"10.1016\/j.ejpb.2023.05.020_b0015","first-page":"419801","article-title":"Prostate cancer in South Africa: pathology based national cancer registry data (1986-2006) and mortality rates (1997-2009)","author":"Urban","year":"2014","journal-title":"Prostate Cancer.2014"},{"key":"10.1016\/j.ejpb.2023.05.020_b0020","doi-asserted-by":"crossref","first-page":"101410","DOI":"10.1016\/j.jddst.2019.101410","article-title":"Docetaxel loaded human serum albumin nanoparticles; synthesis, characterization, and potential of nuclear imaging of prostate cancer","volume":"55","author":"Ertugena","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2023.05.020_b0025","first-page":"2532","article-title":"The diagnosis and treatment of prostate cancer a review","volume":"24","author":"Mark","year":"2017","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejpb.2023.05.020_b0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10637-017-0433-4","article-title":"ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration-resistant prostate cancer","volume":"35","author":"Crabb","year":"2017","journal-title":"Inv. New Drugs"},{"key":"10.1016\/j.ejpb.2023.05.020_b0035","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","article-title":"Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomized open-label trial","volume":"9747","author":"De Bono","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2023.05.020_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2014.04.001","article-title":"Nanoways to overcome docetaxel resistance in prostate cancer","volume":"17","author":"Ganjua","year":"2014","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ejpb.2023.05.020_b0045","first-page":"495","article-title":"Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake","volume":"13","author":"Cho","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2023.05.020_b0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biomaterials.2008.09.014","article-title":"The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma","volume":"30","author":"Lingl","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2023.05.020_b0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/152581602753448577","article-title":"Docetaxel versus paclitaxel for antiangiogenesis","volume":"11","author":"Vacca","year":"2002","journal-title":"J. Hematother. Stem Cell Res."},{"key":"10.1016\/j.ejpb.2023.05.020_b0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1049\/iet-nbt.2017.0001","article-title":"Docetaxel-loaded solid lipid nanoparticles: a novel drug delivery system","volume":"11","author":"Amania","year":"2017","journal-title":"IET Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2023.05.020_b0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.10907","article-title":"Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)","volume":"104","author":"Grant","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejpb.2023.05.020_b0070","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1634\/theoncologist.7-6-516","article-title":"Improvement of oral drug treatment by temporary inhibition of drug transporters and\/or cytochrome P450 in the gastrointestinal tract and liver: an overview","volume":"7","author":"Kruijtzer","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.ejpb.2023.05.020_b0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12938-019-0624-7","article-title":"Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation","volume":"18","author":"Qu","year":"2019","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.ejpb.2023.05.020_b0080","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3109\/10717544.2015.1049720","article-title":"Enhanced tolerance and antitumor efficacy by docetaxel-loaded albumin nanoparticles","volume":"23","author":"Tang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2023.05.020_b0085","first-page":"385","article-title":"Comparison of different crosslinking methods for preparation of docetaxel-loaded albumin nanoparticles","volume":"14","author":"Niknejad","year":"2015","journal-title":"Iran. J. Pharm. Res"},{"key":"10.1016\/j.ejpb.2023.05.020_b0090","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/pros.22637","article-title":"Thermotherapy using magnetic cationic liposomes powerfully suppresses prostate cancer bone metastasis in a novel rat model","volume":"73","author":"Kobayashi","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.ejpb.2023.05.020_b0095","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.2147\/IJN.S24167","article-title":"Synergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubes","volume":"6","author":"Wang","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2023.05.020_b0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.colsurfb.2013.09.010","article-title":"Preparation and evaluation in vitro and in vivo of docetaxel loaded mixed micelles for oral administration","volume":"114","author":"Dou","year":"2014","journal-title":"Colloid Surf. B"},{"key":"10.1016\/j.ejpb.2023.05.020_b0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2013.04.024","article-title":"Oral delivery of taurocholic acid linked heparin-docetaxel conjugates for cancer therapy","volume":"170","author":"Khatun","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.05.020_b0110","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1038\/s41598-020-80529-1","article-title":"An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer","volume":"11","author":"Hambiraj","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2023.05.020_b0115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ctrv.2013.06.008","article-title":"Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents","volume":"40","author":"Bahl","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ejpb.2023.05.020_b0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.colsurfb.2018.11.077","article-title":"Rational design of polymer-lipid nanoparticles for docetaxel delivery","volume":"175","author":"Albano","year":"2019","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ejpb.2023.05.020_b0125","first-page":"2759","article-title":"Chemosensitizer and docetaxel-loaded albumin nanoparticle: overcoming drug resistance and improving therapeutic efficacy","volume":"13","author":"Desale","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejpb.2023.05.020_b0130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2023.05.020_b0135","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.2147\/IJN.S131235","article-title":"Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment","volume":"12","author":"Wu","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2023.05.020_b0140","article-title":"Curcumin-loaded solid lipid nanoparticles enhanced anticancer efficiency in breast cancer","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2023.05.020_b0145","doi-asserted-by":"crossref","DOI":"10.1039\/D0RA03491F","article-title":"Brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems","author":"Duan","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2023.05.020_b0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/nano8020110","article-title":"Development and characterization of solid lipid nanoparticles loaded with a highly active doxorubicin derivative","volume":"8","author":"Barbara","year":"2018","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejpb.2023.05.020_b0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/nano8030159","article-title":"Sustained cytotoxicity of wogonin on breast cancer cells by encapsulation in solid lipid nanoparticles","volume":"8","author":"Jong","year":"2018","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejpb.2023.05.020_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110770","article-title":"PEGylated nanocarriers: A promising tool for targeted delivery to the brain","volume":"187","author":"Gajbhiye","year":"2020","journal-title":"Colloids Surf. B Biointerf."},{"key":"10.1016\/j.ejpb.2023.05.020_b0165","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1021\/acs.biomac.5b01003","article-title":"PEGylated silk nanoparticles for anticancer drug delivery","volume":"16","author":"Wongpinyochit","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2023.05.020_b0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2014.04.017","article-title":"Assessment of PEG on polymeric particles surface, a key step in drug carrier translation","volume":"185","author":"Rabanel","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.05.020_b0175","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jconrel.2010.03.016","article-title":"Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting","volume":"145","author":"Li","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.05.020_b0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties","volume":"42","author":"Moghimi","year":"2003","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"10.1016\/j.ejpb.2023.05.020_b0185","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nano.2012.10.003","article-title":"Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells","volume":"9","author":"Madan","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejpb.2023.05.020_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119688","article-title":"Sustained delivery of epalrestat to the retina using PEGylated solid lipid nanoparticles laden contact lens","volume":"587","author":"Zhu","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.05.020_b0195","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.colsurfb.2017.11.008","article-title":"Magnesium lithospermate B loaded PEGylated solid lipid nanoparticles for improved oral bioavailability","volume":"161","author":"Kang","year":"2018","journal-title":"Colloids Surf B Bio Interf."},{"key":"10.1016\/j.ejpb.2023.05.020_b0200","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1080\/03639045.2017.1293681","article-title":"Nanostructured lipid carriers loaded with simvastatin: effect of PEG\/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity","volume":"43","author":"Safwat","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2023.05.020_b0205","article-title":"PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt (IV) prodrugs: an in vitro study","volume":"15","author":"Arduino","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.05.020_b0210","doi-asserted-by":"crossref","unstructured":"L. Yerga, I. Posadas, C. Torre, Docetaxel-loaded nanoparticles assembled from \u03b2-cyclodextrin\/calixarene giant surfactants: physicochemical properties and cytotoxic effect in prostate cancer and glioblastoma cells, Front. Pharmacol. (8) (2017) 249. <https:\/\/doi.org\/10.3389\/fphar.2017.00249>.","DOI":"10.3389\/fphar.2017.00249"},{"key":"10.1016\/j.ejpb.2023.05.020_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119386","article-title":"Fabrication and in vivo evaluation of ligand appended paclitaxel and artemether loaded lipid nanoparticulate systems for the treatment of NSCLC: a nanoparticle assisted combination oncotherapy","volume":"583","author":"Khatri","year":"2020","journal-title":"Int. J. of Pharmaceutics"},{"key":"10.1016\/j.ejpb.2023.05.020_b0220","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1021\/mp4006968","article-title":"Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation","volume":"11","author":"Youssef","year":"2014","journal-title":"Mol. Pharmaceutics"},{"key":"10.1016\/j.ejpb.2023.05.020_b0225","first-page":"1379","article-title":"Who role and guidelines in stability study of pharmaceuticals: a regulatory perspective","volume":"3","author":"Tangri","year":"2012","journal-title":"Int. J. Res. Pharm. Biomed. Sci."},{"key":"10.1016\/j.ejpb.2023.05.020_b0230","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1166\/jbn.2016.2152","article-title":"Cisplatin loaded poly (l-glutamic acid)-g-methoxy poly (ethylene glycol) complex nanoparticles for potential cancer therapy: preparation, in vitro and in vivo evaluation","volume":"12","author":"Yu","year":"2016","journal-title":"J. Biomed. Nanotechnol"},{"key":"10.1016\/j.ejpb.2023.05.020_b0235","first-page":"1","article-title":"Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapy","volume":"3","author":"Baskararaj","year":"2020","journal-title":"Biotech"},{"key":"10.1016\/j.ejpb.2023.05.020_b0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejps.2016.07.007","article-title":"Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy","volume":"92","author":"Khare","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.05.020_b0245","first-page":"327","article-title":"Targeting solid lipid nanoparticles with anisamide for docetaxel delivery to prostate cancer: preparation, optimization, and in-vitro evaluation","volume":"20","author":"Jalilian","year":"2021","journal-title":"Iran J. Pharm. Res. Winter"},{"key":"10.1016\/j.ejpb.2023.05.020_b0250","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.2147\/IJN.S258856","article-title":"Preparation and evaluation of cabazitaxel-loaded bovine serum albumin nanoparticles for prostate cancer","volume":"15","author":"Wan","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2023.05.020_b0255","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/IJN.S173954","article-title":"Doxorubicin and indocyanine green loaded superparamagn etic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma","volume":"14","author":"Shen","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2023.05.020_b0260","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2016.12.019","article-title":"Blood-brain barrier penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer","volume":"246","author":"He","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2023.05.020_b0265","first-page":"105","article-title":"Development of RP-HPLC method for simultaneous determination of docetaxel and curcumin in rat plasma: validation and stability","volume":"12","author":"Kim","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.05.020_b0270","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2023.05.020_b0275","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.2174\/1381612824666180730161721","article-title":"Impact of PEGylated nanoparticles on tumor targeted drug delivery","volume":"28","author":"Mozar","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejpb.2023.05.020_b0280","article-title":"Solvent-free esterification of stearic acid and ethylene glycol with heterogeneous catalysis in a stirred batch microwave reactor","volume":"712","author":"Hiware","year":"2020","journal-title":"SN Appl. Sci."},{"key":"10.1016\/j.ejpb.2023.05.020_b0285","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijpharm.2016.01.075","article-title":"Self-assembly PEGylation assists SLN-paclitaxel delivery inducing cancer cell apoptosis upon internalization","volume":"501","author":"Arranja","year":"2016","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ejpb.2023.05.020_b0290","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/jps.23522","article-title":"Docetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro, and in vivo evaluations","volume":"102","author":"Mosallaei","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.05.020_b0295","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1211\/jpp.61.11.0007","article-title":"Preparation, and pharmacokinetics of docetaxel based on nanostructured lipid carriers","volume":"61","author":"Li","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2023.05.020_b0300","first-page":"53","article-title":"Modulating drug release rate from partially silica-coated bicellar nano disc by incorporating PEGylated Phospholipid, Bioconjugate","volume":"28","author":"Lin","year":"2017","journal-title":"Chem"},{"key":"10.1016\/j.ejpb.2023.05.020_b0305","doi-asserted-by":"crossref","first-page":"155102","DOI":"10.1088\/1361-6528\/ab5c56","article-title":"Design in silico modeling and functionality theory of folate-receptor-targeted myricetin loaded bovine serum albumin nanoparticle formulation for cancer treatment","volume":"31","author":"Kunjiappan","year":"2020","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ejpb.2023.05.020_b0310","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1021\/nl302638g","article-title":"PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics","volume":"12","author":"Perry","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejpb.2023.05.020_b0315","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2014.12.022","article-title":"Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly (L-glutamic acid)-g-methoxy poly (ethylene glycol) complex nanoparticles for tumor therapy","volume":"205","author":"Yu","year":"2015","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112300142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112300142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:51:31Z","timestamp":1760547091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112300142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":63,"alternative-id":["S093964112300142X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.05.020","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, development, and in-vitro\/in-vivo evaluation of docetaxel-loaded PEGylated solid lipid nanoparticles in prostate cancer therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}